Pathogenesis and treatment of virus-induced autoimmune diabetes: novel insights gained from the RIP-LCMV transgenic mouse model.
von Herrath
M G
MG
Department of Neuropharmacology, Scripps Research Institute, La Jolla, CA 92037, USA.
Homann
D
D
Gairin
J E
JE
Oldstone
M B
MB
D000818:Animals; D018414:CD8-Positive T-Lymphocytes / Q000276:immunology*; D016207:Cytokines / Q000096:biosynthesis; D003922:Diabetes Mellitus, Type 1 / Q000276:immunology* / Q000628:therapy / Q000821:virology; D006801:Humans; D007167:Immunotherapy; D007328:Insulin / Q000096:biosynthesis / Q000235:genetics*; D007515:Islets of Langerhans / Q000276:immunology* / Q000473:pathology; D008214:Lymphocytes / Q000276:immunology* / Q000473:pathology; D008217:Lymphocytic choriomeningitis virus; D008285:Major Histocompatibility Complex; D051379:Mice; D008822:Mice, Transgenic; D018448:Models, Immunological; D051381:Rats; D018417:Th1 Cells / Q000276:immunology; D018418:Th2 Cells / Q000276:immunology
D016207:Cytokines; D007328:Insulin